These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 8417126)

  • 21. Reactivity of purified complement component 3b with bovine neutrophils and modulation of complement receptor 1.
    Di Carlo AL; Paape MJ; Miller RH
    Am J Vet Res; 1996 Feb; 57(2):151-6. PubMed ID: 8633799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Temporal adaptation of human neutrophil metabolic responsiveness to the peptide formylmethionyl-leucyl phenylalanine: a comparison between human neutrophils and granule-depleted neutrophil cytoplasts.
    Dahlgren C
    Cell Biochem Funct; 1990 Jan; 8(1):57-64. PubMed ID: 2160338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of formyl peptide receptor expression by IL-10 in human monocytes and neutrophils.
    Thivierge M; Parent JL; Stankova J; Rola-Pleszczynski M
    J Immunol; 1999 Mar; 162(6):3590-5. PubMed ID: 10092818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway.
    Nilsson G; Johnell M; Hammer CH; Tiffany HL; Nilsson K; Metcalfe DD; Siegbahn A; Murphy PM
    J Immunol; 1996 Aug; 157(4):1693-8. PubMed ID: 8759757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complement-induced expression of cryptic receptors on the neutrophil surface: a mechanism for regulation of acute inflammation in trauma.
    Solomkin JS; Cotta LA; Ogle JD; Brodt JK; Ogle CK; Satoh PS; Hurst JM; Alexander JW
    Surgery; 1984 Aug; 96(2):336-44. PubMed ID: 6087484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biologically active conformer of the effector region of human C5a and modulatory effects of N-terminal receptor binding determinants on activity.
    Finch AM; Vogen SM; Sherman SA; Kirnarsky L; Taylor SM; Sanderson SD
    J Med Chem; 1997 Mar; 40(6):877-84. PubMed ID: 9083476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of density changes and chemotactic receptors of leukocytes from chronic hemodialysis and peritoneal dialysis patients.
    Lewis SL; Van Epps DE; Chenoweth DE
    Blood Purif; 1987; 5(2-3):138-54. PubMed ID: 3040039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. C5a receptor modulation on neutrophils and monocytes from chronic hemodialysis and peritoneal dialysis patients.
    Lewis SL; Van Epps DE; Chenoweth DE
    Clin Nephrol; 1986 Jul; 26(1):37-44. PubMed ID: 3488153
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of C1q receptor expression on human phagocytic cells: effects of PDBu and fMLP.
    Bobak DA; Frank MM; Tenner AJ
    J Immunol; 1986 Jun; 136(12):4604-10. PubMed ID: 3486907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of C1q receptor expression on human polymorphonuclear leukocytes.
    Jack RM; Lowenstein BA; Nicholson-Weller A
    J Immunol; 1994 Jul; 153(1):262-9. PubMed ID: 7911495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma clearance of the human C5a anaphylatoxin by binding to leucocyte C5a receptors.
    Oppermann M; Götze O
    Immunology; 1994 Aug; 82(4):516-21. PubMed ID: 7835913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of pentoxifylline on human polymorphonuclear neutrophil responses to TNF in whole blood.
    Elbim C; Lefebvre M; Hakim J; Gougerot-Pocidalo MA
    Eur Cytokine Netw; 1995; 6(2):113-20. PubMed ID: 7578989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Different endocytosis pathways of the C5a receptor and the N-formyl peptide receptor.
    Suvorova ES; Gripentrog JM; Miettinen HM
    Traffic; 2005 Feb; 6(2):100-15. PubMed ID: 15634211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Receptor class desensitization of leukocyte chemoattractant receptors.
    Didsbury JR; Uhing RJ; Tomhave E; Gerard C; Gerard N; Snyderman R
    Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11564-8. PubMed ID: 1763071
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Receptor-operated activation of polymorphonuclear leukocytes: different effects of NAP-1/IL-8 and fMet-Leu-Phe or C5a.
    Wirthmueller U; Baggiolini M; de Weck AL; Dahinden CA
    Biochem Biophys Res Commun; 1991 May; 176(3):972-8. PubMed ID: 1645549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of pregnancy on polymorphonuclear leukocyte function.
    Crouch SP; Crocker IP; Fletcher J
    J Immunol; 1995 Dec; 155(11):5436-43. PubMed ID: 7594561
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Small molecular probes for G-protein-coupled C5a receptors: conformationally constrained antagonists derived from the C terminus of the human plasma protein C5a.
    Wong AK; Finch AM; Pierens GK; Craik DJ; Taylor SM; Fairlie DP
    J Med Chem; 1998 Aug; 41(18):3417-25. PubMed ID: 9719594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutation of aspartate 82 of the human C5a receptor abolishes the secretory response to human C5a in transfected rat basophilic leukemia cells.
    Monk PN; Pease JE; Marland G; Barker MD
    Eur J Immunol; 1994 Nov; 24(11):2922-5. PubMed ID: 7957584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of the binding of fluorescent C5a and C3a to human peripheral blood leukocytes.
    van Epps DE; Chenoweth DE
    J Immunol; 1984 Jun; 132(6):2862-7. PubMed ID: 6373920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of low-density lipoproteins on polymorphonuclear leukocyte functions in vitro.
    Bonneau C; Couderc R; Roch-Arveiller M; Giroud JP; Raichvarg D
    J Lipid Mediat Cell Signal; 1994 Sep; 10(3):203-12. PubMed ID: 7812672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.